Skip to main content

Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform

HONG KONG, Jan. 27, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has successfully completed a HK$150 million share placement, strengthening its balance sheet to accelerate investment in artificial intelligence and platform upgrades. The shares were priced at HK$3.32 per share, with the shares placed representing approximately 3.26% of the Company’s enlarged issued share capital following completion of the subscription. Fangzhou plans to allocate approximately 90% of the net proceeds after deducting related costs and expenses to accelerate development of the Company’s AI-driven chronic disease management platform. This encompasses model development and optimization, infrastructure and computational resource expansion, talent...

Continue reading

Twin Hospitality Group Files Voluntary Chapter 11 Petitions to Strengthen Capital Structure

DALLAS, Jan. 26, 2026 (GLOBE NEWSWIRE) — Twin Hospitality Group Inc. (Nasdaq: TWNP), the parent company of Twin Peaks Restaurant, today announced it has commenced voluntary chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of Texas. Twin Hospitality plans to use the filings to deleverage the balance sheet, maximize value for its stakeholders, and support the continued growth of its brands. Twin Hospitality develops and operates the specialty casual dining restaurant concepts, Twin Peaks and Smokey Bones. Throughout the chapter 11 process, Twin Hospitality expects the brands will remain open and operating as usual and will continue delivering their signature guest experiences. Trading of Twin Hospitality Group’s securities on NASDAQ is expected to continue with a “Q” suffix during this period. “Twin...

Continue reading

Micron Breaks Ground on Advanced Wafer Fabrication Facility in Singapore

Approximately $24 billion investment over 10 years will support long-term manufacturing requirements and AI-driven demand SINGAPORE, Jan. 27, 2026 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) broke ground today on an advanced wafer fabrication facility located within the company’s existing NAND manufacturing complex in Singapore. This new facility represents a planned investment of approximately US $24 billion (SG $31 billion) over 10 years and is designed to ultimately provide 700,000 square feet of cleanroom space. Wafer output is scheduled to begin in the second half of calendar 2028, helping Micron address growing market demand for NAND technology driven by the rapid expansion of AI and data-centric applications. The groundbreaking ceremony for this facility, Singapore’s first double-story wafer manufacturing...

Continue reading

Runway Growth Finance Corp. Commences Offering of Notes

MENLO PARK, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (“Runway Growth” or the “Company”) (Nasdaq: RWAY), a leading provider of flexible capital solutions to late and growth-stage companies seeking an alternative to raising equity, today announced that it has commenced an underwritten offering of unsecured notes (the “Notes”), subject to market and other conditions. The Company has applied for the Notes to be listed and trade on the Nasdaq Global Select Market. If approved for listing, the Company expects the Notes to begin trading within 30 days from the original issue date. The interest rate and other terms of the Notes will be determined at the time of pricing of the offering. The Company intends to use the net proceeds from this offering to repay outstanding indebtedness, including to redeem all or...

Continue reading

FAT Brands Inc. Files Voluntary Chapter 11 Petitions to Bolster Capital Structure

LOS ANGELES, Jan. 26, 2026 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (the “Company”), today announced it has commenced voluntary chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of Texas. FAT Brands plans to use the filings to deleverage the balance sheet, maximize value for its stakeholders, and support continued growth of its brands. FAT Brands’ portfolio of 18 restaurant concepts encompasses more than 2,200 locations worldwide. Iconic brands such as Fatburger, Johnny Rockets, Round Table Pizza, among others, are expected to remain operating as usual during the chapter 11 process, and will continue to provide their signature dining experiences. Trading of FAT Brands’ securities on NASDAQ is expected to continue with a “Q” suffix during this period. “Our dynamic...

Continue reading

OFA Group Clarifies Scope and Positioning of Hearth Platform as Non-Custodial Technology Infrastructure

LOS ANGELES, CA, Jan. 26, 2026 (GLOBE NEWSWIRE) — OFA Group (NASDAQ: OFAL), a publicly traded company operating at the intersection of architecture, technology, and asset management, today issued the following clarification regarding the scope, functionality, and regulatory positioning of its Hearth platform. This clarification is intended to provide additional transparency following Hearth’s initial launch announcement on January 26, 2026 and to ensure accurate understanding of the platform’s role within OFA Group’s broader digital infrastructure strategy. Clarification of Platform Nature Hearth is operated by Hearth Labs, Inc., a wholly owned subsidiary of OFA Group, and is designed exclusively as a non-custodial, technology-only infrastructure platform supporting digital record-keeping, data representation, and workflow coordination...

Continue reading

Jura Announces Dismissal in Full of PEL’s Appeal against certain reliefs granted in the Settlement Agreement Arbitral Award

CALGARY, Alberta, Jan. 26, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company“) is pleased to announce that the High Court of Justice, Business and Property Courts of England and Wales Commercial Court (the “UK Court”) has dismissed in full the appeal filed by Petroleum Exploration (Private) Limited (“PEL”) challenging the arbitrator’s jurisdiction in respect of certain reliefs granted to Jura’s operating subsidiaries, Spud Energy (Pty) Limited (“Spud”) and Frontier Holdings Limited (“FHL”) (together, the “Claimants”) in the Settlement Agreement arbitral award. PEL is the operator of the Badin IV South and Badin IV North petroleum concessions (together, the “Badin Assets”) in each of which FHL holds a 27.5% working interest. As previously announced, in December 2024 the International...

Continue reading

Erdene Announces $25 Million Bought Deal Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Jan. 26, 2026 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQB: ERFCF) (“Erdene” or the “Company”) is pleased to announce that it has entered into an agreement with Paradigm Capital Inc. (“Paradigm”), pursuant to which Paradigm, as co-lead underwriter and joint bookrunner with National Bank Financial Inc., on behalf of a syndicate of underwriters (Paradigm and the syndicate, together, the “Underwriters”), has agreed to purchase, on a “bought deal” private placement basis, 2,809,000 common shares of the Company (the “Common Shares“) at a price of $8.90 per Common Share (“Issue Price“) for aggregate gross proceeds of $25,000,100 (the...

Continue reading

Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment

NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on use of Ryoncil® (remestemcel-L-rknd) since commercially available in March 2025 for the approved label in children 2 months and older with steroid-refractory acute graft-versus-host disease (SR-aGvHD). Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by the U.S. Food & Drug Administration (FDA) for any indication.1 Of the first 25 patients treated with Ryoncil® in a ‘real-world’ clinical setting post launch, 21 were alive (84%) and completed the initial 28-day treatment regimen as per the FDA approval label. The four patients who did not complete the 28-day treatment course had been offered and failed other therapies prior...

Continue reading

Provident Financial Services, Inc. Announces Authorization of New Stock Repurchase Program

ISELIN, N.J., Jan. 26, 2026 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (the “Company”) today announced that its Board of Directors has authorized the Company’s tenth stock repurchase program, which will begin upon the completion of the existing stock repurchase program, which has 814,247 shares remaining available for repurchase. Under the new authorization, together with the remaining shares available under the existing authorization, the Company may repurchase up to 2.15% of its currently outstanding shares of common stock, or approximately 2.81 million shares. Repurchases may be made from time to time through open market purchases, unsolicited negotiated transactions, block trades, or pursuant to any trading plan adopted in accordance with Rule 10b5‑1 of the Securities and Exchange Commission. The repurchase program...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.